When is Drug Treatment not Necessary in Epilepsy? Factors that should Influence the Decision to Prescribe

Hauser W.A. , Annegers J.F. , Anderson V.E. Epidemiology and the genetics of epilepsy. In: Ward A.A. , Penry J.K. , Purpura D. , eds. Epilepsy.New York: Raven Press, 1983: 267–94

Marson A.G. , Kadir Z.A. , Chadwick D.W. New anti-epileptic drugs. A systematic review of their efficacy and tolerability. BMJ 1996; 313: 1169–74

Stroink H. , van Donselaar C.A. , Geerts A.T. , Peters A.C.B. , Brouwer O.F. , Arts W.F.M. The accuracy of the diagnosis of paroxysmal events in children. Neurology 2003; 60: 979–82

Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985; 20: 29–37

Trostle J.A. Medical compliance as an ideology. Soc Sci Med 1988; 27: 1299–308

Houston E.C. , Cunningham C.C. , Metcalfe E. , Newton R. The information needs and understanding of 5 to 10 year old children with epilepsy, asthma or diabetes. Seizure 2000; 9: 340–3

Haynes R.B. , Devereaux P.J. , Gyatt G.A. Physicians’ and patients’ choices in evidence based practice. BMJ 2002; 324: 1350

First Seizure Trial Group. Randomized clinical trial on the efficacy of anti-epileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 1993; 43: 478–83

Camfield P.R. , Camfield C.S. , Dooley J.M. , Tibbles J.A. , Fung T. , Garner B. Epilepsy after a first unprovoked seizure in childhood. Neurology 1985; 35: 1657–60

Cockerell O.C. , Johnson A.L. , Goodridge D.M.G. , Sander JWAS , Shorvon S.D. The remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995; 346: 140–4

Placencia M. , Sander JWAS , Shorvon S.D. , Alarcon F. , Roman M. , Cacante S. Anti-epileptic drug treatment in a community health care setting in Northern Ecuador: a prospective 12 month assessment. Epilepsy Res 1993; 14: 237–44

Osuntokun B.O. , Adeuja A.O.G. , Nottidge V.A. . Prevalence of epilepsy in Africans: a community based study. Epilepsia 1987; 28: 272–9

Tekle-Himanot R. , Forsgren L. , Abebe M. . Clinical and electroencephalographic characteristics of epilepsy in rural Ethiopia: a community based study. Epilepsy Res 1990; 7: 230–9

Keranen T. , Riekkinen P.J. Remission of seizures in untreated epilepsy. BMJ 1993; 307: 483

Jilek-Aall L. , Jilek W. , Miller J.R. Clinical and genetic aspects of seizure disorders prevalent in an isolated African population. Epilepsia 1979; 20: 613–22

Feksi A.T. , Kaamugish J. , Sanders JWAS , Jatiti S. , Shorvon S.D. Comprehensive primary health care anti-epileptic drug treatment programme in rural and semi-rural Kenya. Lancet 1991; 337: 406–9

Reynolds E.H. , Hellar A.J. , Elwes R.D.C. . Factors influencing prognosis of newly diagnosed epilepsy. Epilepsia 1989; 30: 648

Elwes R.D.C. , Johnson A.L. , Reynolds E.H. The course of untreated epilepsy. BMJ 1988; 297: 948–50

Van Donselaar C.A. , Brouwer O.F. , Geerts A.T. , Arts W.F. , Stroink A.H. , Peters A.C. Clinical course of untreated tonic—clonic seizures in childhood: prospective, hospital based study. BMJ 1997; 314: 410–14

Koh S. , Jensen P.E. Topiramate blocks acute and chronic epileptogenesis in a rat model of perinatal hypoxic encephalopathy. Epilepsia 1999; 40(suppl 7): 5–6

Temkin N.R. Personal communication cited in Sander JWAS, White HS. Disease modification in epilepsy. Prog Neurol Psychiatry 2000; 5(2)

Hughes J.R. Long-term clinical and EEG changes in patients with epilepsy: Arch Neurol 1985; 43: 213–23

Chadwick D. The MESS Study. Lecture delivered to 29th Annual Conference of the British Paediatric Neurology Association, Liverpool, 2003

Newton R.W. Randomised controlled trials of phenobarbitone and valproate in febrile convulsions. Arch Dis Child 1988; 63: 1189–91

Newton R. Neurological networks. Devel Med Child Neurol 2002; 44: 795